LEXARIA BIOSCIENCE CORP. (LEXX) Current Ratio
- Current ratio · latest quarter: Value 10.60×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 10.60× | Current assets / current liabilities. $4.06M ÷ $383.41K ≈ 10.60× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 4.06M USD | Assets, Current |
| Current obligations | 383.41K USD | Liabilities, Current |
| Cash and equivalents | 3.50M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 0.00 USD | Marketable Securities, Current |
| Customer receivables | 49.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | (m) | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $4.06M | $383.41K | $3.50M | $0.00 | $49.00K | (m) | (m) | (m) | 10.60× |
| 2026-02-28 | $5.77M | $214.67K | $5.10M | $0.00 | $42.03K | (m) | (m) | (m) | 26.88× |
| 2025-11-30 | $5.36M | $1.46M | $4.30M | $0.00 | $88.04K | (m) | (m) | (m) | 3.68× |
| 2025-08-31 | $3.47M | $1.49M | (m) | $22.09K | $368.36K | (m) | (m) | (m) | 2.32× |
| 2025-05-31 | $5.81M | $1.49M | $4.60M | $33.54K | $358.13K | (m) | (m) | (m) | 3.90× |
| 2025-02-28 | $7.72M | $1.82M | $6.50M | $73.92K | $331.17K | (m) | (m) | (m) | 4.24× |
| 2024-11-30 | $8.83M | $297.80K | (m) | $39.88K | $263.49K | (m) | (m) | (m) | 29.64× |
| 2024-08-31 | $7.90M | $1.10M | (m) | $55.81K | $154.48K | (m) | (m) | (m) | 7.18× |
| 2024-05-31 | $9.09M | $156.05K | (m) | $46.31K | $208.44K | (m) | (m) | (m) | 58.27× |
| 2024-02-29 | $5.42M | $81.72K | (m) | $87.70K | $357.09K | (m) | (m) | (m) | 66.29× |
| 2023-11-30 | $2.69M | $124.52K | (m) | $72.43K | $534.73K | (m) | (m) | (m) | 21.63× |
| 2023-08-31 | $2.15M | $267.74K | (m) | $125.64K | $126.69K | (m) | (m) | (m) | 8.03× |
| 2023-05-31 | $4.24M | $1.06M | (m) | $269.56K | $172.28K | $0.00 | (m) | (m) | 4.01× |
| 2023-02-28 | $4.00M | $223.13K | $3.27M | $267.70K | $136.80K | $7.59K | (m) | (m) | 17.94× |
| 2022-11-30 | $5.36M | $281.52K | $4.53M | $269.71K | $286.32K | $9.94K | (m) | (m) | 19.04× |
| 2022-08-31 | $6.98M | $194.04K | (m) | $347.33K | $201.78K | $38.42K | (m) | (m) | 35.96× |
| 2022-05-31 | $8.29M | $206.83K | $7.05M | $288.03K | $154.87K | $40.18K | (m) | (m) | 40.09× |
| 2022-02-28 | $10.57M | $165.54K | $8.36M | $552.32K | $506.62K | $31.93K | (m) | (m) | 63.86× |
| 2021-11-30 | $10.90M | $237.70K | $9.68M | $493.42K | $461.51K | $26.97K | (m) | (m) | 45.86× |
| 2021-08-31 | $12.44M | $153.28K | $10.92M | $833.84K | $342.40K | $29.65K | (m) | (m) | 81.18× |
| 2021-05-31 | $9.69M | $221.22K | $8.11M | $400.74K | $954.10K | $51.74K | (m) | (m) | 43.78× |
| 2021-02-28 | $10.95M | $399.39K | $9.35M | $470.63K | $627.78K | $137.28K | (m) | (m) | 27.41× |
| 2020-11-30 | $1.31M | $242.47K | $525.34K | $43.73K | $427.33K | $125.96K | (m) | (m) | 5.39× |
| 2020-08-31 | $1.93M | $225.92K | $1.29M | $19.32K | $313.93K | $116.87K | (m) | (m) | 8.53× |
| 2020-05-31 | $2.53M | $90.97K | $2.03M | $18.28K | $253.96K | $132.92K | (m) | (m) | 27.79× |
| 2020-02-29 | $1.18M | $63.29K | $739.99K | $23.62K | $227.27K | $124.41K | (m) | (m) | 18.65× |
| 2019-11-30 | $1.91M | $130.23K | $1.33M | $22.64K | $325.90K | $133.56K | (m) | (m) | 14.68× |
| 2019-08-31 | $1.82M | $184.51K | $1.29M | $64.21K | $273.14K | $127.40K | (m) | (m) | 9.86× |
| 2019-05-31 | $2.61M | $132.29K | $2.00M | $74.84K | $225.83K | $188.28K | (m) | (m) | 19.71× |
| 2019-02-28 | $3.64M | $500.08K | $3.09M | $71.13K | $219.10K | $108.02K | $159.94K | (m) | 7.28× |
| 2018-11-30 | $3.23M | $129.94K | $2.64M | $71.02K | $214.87K | $116.67K | (m) | (m) | 24.86× |
| 2018-08-31 | $2.28M | $43.64K | $1.73M | $10.15K | $265.75K | $87.23K | (m) | (m) | 52.34× |
| 2018-05-31 | $2.59M | $71.64K | $2.06M | $17.62K | $267.78K | $76.47K | (m) | (m) | 36.11× |
| 2018-02-28 | $2.75M | $69.04K | $2.32M | (m) | $188.28K | $62.53K | (m) | (m) | 39.76× |
| 2017-11-30 | $2.42M | $95.70K | $2.21M | (m) | $71.92K | $77.44K | (m) | (m) | 25.26× |
| 2017-08-31 | $2.80M | $92.35K | $2.53M | (m) | $45.29K | $67.17K | (m) | (m) | 30.27× |
| 2017-05-31 | $3.08M | $40.00K | $2.79M | (m) | $57.40K | $128.38K | (m) | (m) | 76.98× |
| 2017-02-28 | $803.69K | $333.55K | $523.63K | (m) | $23.63K | $143.37K | (m) | (m) | 2.41× |
| 2016-11-30 | $1.07M | $468.55K | $124.25K | (m) | $649.05K | $150.36K | (m) | (m) | 2.28× |
| 2016-08-31 | $510.17K | $433.88K | $93.41K | (m) | $131.08K | $134.72K | (m) | (m) | 1.18× |
| 2016-05-31 | $279.36K | $331.54K | $37.10K | (m) | $14.57K | $126.77K | (m) | (m) | 0.84× |
| 2016-02-29 | $337.39K | $284.29K | $40.22K | (m) | $43.66K | $141.44K | (m) | (m) | 1.19× |
| 2015-08-31 | $674.73K | $55.13K | $260.07K | (m) | $31.38K | $167.99K | (m) | (m) | 12.24× |
| 2015-05-31 | $1.16M | $62.60K | $832.10K | (m) | $21.63K | $79.34K | (m) | (m) | 18.50× |
| 2015-02-28 | $1.16M | $38.15K | $792.02K | (m) | $35.02K | $77.59K | (m) | (m) | 30.35× |
| 2014-11-30 | $2.20M | $789.36K | $431.07K | (m) | $75.33K | $18.80K | (m) | (m) | 2.79× |
| 2014-08-31 | $2.57M | $918.04K | $703.03K | (m) | $97.00K | $0.00 | (m) | (m) | 2.80× |
| 2014-07-31 | $1.20M | $957.42K | $578.48K | (m) | $98.68K | (m) | (m) | (m) | 1.25× |
| 2014-04-30 | $1.47M | $1.05M | $951.74K | (m) | $100.32K | (m) | (m) | (m) | 1.40× |
| 2014-01-31 | $164.65K | $1.47M | $28.66K | (m) | $130.65K | (m) | (m) | (m) | 0.11× |
| 2013-10-31 | $146.27K | $1.42M | $65.54K | (m) | $79.22K | (m) | (m) | (m) | 0.10× |
| 2013-07-31 | $182.33K | $1.40M | $27.53K | (m) | $151.82K | (m) | (m) | (m) | 0.13× |
| 2013-04-30 | $216.21K | $1.48M | $44.53K | (m) | $167.22K | (m) | (m) | (m) | 0.15× |
| 2013-01-31 | $284.78K | $1.55M | $38.94K | (m) | $239.91K | (m) | (m) | (m) | 0.18× |
| 2012-10-31 | $472.93K | $1.71M | $180.51K | (m) | $290.94K | (m) | (m) | (m) | 0.28× |
| 2012-07-31 | $517.26K | $1.84M | $16.45K | (m) | $497.87K | (m) | (m) | (m) | 0.28× |
| 2012-04-30 | $264.50K | $1.81M | $120.56K | (m) | $139.52K | (m) | (m) | (m) | 0.15× |
| 2012-01-31 | $322.82K | $1.68M | $140.48K | (m) | $176.44K | (m) | (m) | (m) | 0.19× |
| 2011-10-31 | $264.23K | $1.08M | $31.20K | (m) | $230.88K | (m) | (m) | (m) | 0.24× |
| 2011-07-31 | $730.32K | $876.74K | $494.44K | (m) | $231.61K | (m) | (m) | (m) | 0.83× |
| 2010-10-31 | $140.21K | $1.05M | $62.99K | (m) | $74.88K | (m) | (m) | (m) | 0.13× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |